Capsule Benefits

Each TussiCaps^® capsule contains a precise, consistent dose of hydrocodone and chlorpheniramine, so dosing is easy for patients to get right every time. In a recent Harris Interactive^® poll of 932 adult prescription cough syrup users, patients welcomed the potential benefits of a cough medicine in a capsule.*

73% prefer capsules over oral liquids (ie, syrup or suspension)

90% reported they would be extremely, very, or somewhat interested in prescription cough medicine in the form of a capsule

If you would prefer a hydrocodone antitussive capsule for your patients to treat serious cough, remember there's only one—TussiCaps^®.

*Survey conducted online by Harris Interactive for Covidien between July 30 and August 1, 2008, among 932 US adults. No estimates of theoretical sampling error can be calculated; a full methodology is available.

Harris Interactive is a registered trademark of Harris Interactive, Inc.

IMPORTANT RISK INFORMATION
TussiCaps^® (hydrocodone polistirex and chlorpheniramine polistirex) extended-release capsules are indicated for relief of cough and upper respiratory symptoms associated with allergy or cold in adults and children 6 years of age and older.

TussiCaps^® is contraindicated in the presence of known allergy or sensitivity to hydrocodone or chlorpheniramine. The most common adverse reactions associated with TussiCaps^® are sedation, drowsiness, and mental clouding, which may impair the mental and/or physical abilities required for potentially hazardous tasks.